Amonafide - ChemGenex Pharmaceuticals
Alternative Names: CGX-571; FA 142; Nafidimide; NSC 308847; QuinamedLatest Information Update: 25 Sep 2021
At a glance
- Originator Abbott GmbH & Co. KG
- Class Amines; Antineoplastics; Isoquinolines; Naphthalimides; Small molecules
- Mechanism of Action DNA inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Cancer; Endometrial cancer; Ovarian cancer; Prostate cancer
Most Recent Events
- 24 Jan 2013 Discontinued - Phase-II for Breast cancer in USA (IV)
- 24 Jan 2013 Discontinued - Phase-II for Ovarian cancer in USA (IV)
- 24 Jan 2013 Discontinued - Phase-II for Prostate cancer in USA (IV)